Ravindra Gupta: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
No edit summary
expanding a little around his Time 100
Line 6: Line 6:
Gupta gained his undergraduate medical degree from Cambridge University in 1997 and then clinical degree from Oxford University in 2001, whilst completing a Master in Public Health at Harvard School of Public Health (1998-1999).
Gupta gained his undergraduate medical degree from Cambridge University in 1997 and then clinical degree from Oxford University in 2001, whilst completing a Master in Public Health at Harvard School of Public Health (1998-1999).
He subsequently trained in infectious diseases in Oxford and The Hospital for Tropical Diseases (UCLH).
He subsequently trained in infectious diseases in Oxford and The Hospital for Tropical Diseases (UCLH).

== Biography ==
⚫
Gupta is married with three children.


== Career ==
== Career ==
Gupta's research program centers on HIV, from basic science of how the virus interacts with human cells and the immune system, through to global studies on the emerging problem of drug resistant HIV.
Gupta's research program centers on HIV, from basic science of how the virus interacts with human cells and the immune system, through to global studies on the emerging problem of drug resistant HIV.


Gupta was formerly Professor at University College London (2016-2019) <ref>{{cite web|date=28 June 2018|title=Professor Ravindra Gupta|url=https://www.ucl.ac.uk/infection-immunity/people/professor-ravindra-gupta|accessdate=5 March 2019|website=Ucl.ac.uk}}</ref><ref>{{cite web|title=Ravi Gupta|url=https://www.ahri.org/scientist/ravi-gupta/|accessdate=5 March 2019|website=Ahri.org}}</ref> He is head of the Gupta Lab and has been a Wellcome Trust Fellowship holder since 2007.<ref>{{cite web|title=UCL - London's Global University|url=https://www.ucl.ac.uk/gupta-lab/|accessdate=5 March 2019|website=Ucl.ac.uk}}</ref> In March 2019 it was reported that Gupta had led a team demonstrating HIV remission in a [[HIV/AIDS|HIV]] positive man with advanced [[Hodgkin's lymphoma]] following an 'unrelated' [[stem cell transplant]], the so-called 'London Patient'.<ref>{{cite web|date=5 March 2019|title=UK man 'free' of HIV with new stem cells|url=https://www.bbc.com/news/health-47421855|accessdate=5 March 2019|website=Bbc.co.uk}}</ref><ref>{{cite web|date=5 March 2019|title=London patient becomes second adult to be cleared of HIV|url=https://www.theguardian.com/society/2019/mar/05/london-patient-becomes-second-man-to-be-cleared-of-aids-virus|accessdate=5 March 2019|website=Theguardian.com|publisher=}}</ref><ref>{{cite web|author=[[Apoorva Mandavilli]]|date=4 March 2019|title=H.I.V. Is Reported Cured in a Second Patient, a Milestone in the Global AIDS Epidemic|url=https://www.nytimes.com/2019/03/04/health/aids-cure-london-patient.html|accessdate=5 March 2019|website=Nytimes.com}}</ref>
Gupta was formerly Professor at University College London (2016-2019) <ref>{{cite web|date=28 June 2018|title=Professor Ravindra Gupta|url=https://www.ucl.ac.uk/infection-immunity/people/professor-ravindra-gupta|accessdate=5 March 2019|website=Ucl.ac.uk}}</ref><ref>{{cite web|title=Ravi Gupta|url=https://www.ahri.org/scientist/ravi-gupta/|accessdate=5 March 2019|website=Ahri.org}}</ref> He is head of the Gupta Lab and has been a Wellcome Trust Fellowship holder since 2007.<ref>{{cite web|title=UCL - London's Global University|url=https://www.ucl.ac.uk/gupta-lab/|accessdate=5 March 2019|website=Ucl.ac.uk}}</ref>

⚫
Gupta's lab has teams in the UK and Durban, South Africa. The lab focuses on two areas:


⚫
Gupta's lab has teams in the UK and Durban, South Africa. The lab focuses on two areas:
* Studying  HIV drug resistance to protease / integrase inhibitors and implications for global scale up of antiretroviral therapy.<ref>{{Cite web|title=Ravindra Gupta - CITIID|url=https://www.citiid.cam.ac.uk/ravindra-gupta/|access-date=2020-09-23|website=Cambridge Institute of Therapeutic Immunology & Infectious Disease|language=en-GB}}</ref>
* Studying  HIV drug resistance to protease / integrase inhibitors and implications for global scale up of antiretroviral therapy.<ref>{{Cite web|title=Ravindra Gupta - CITIID|url=https://www.citiid.cam.ac.uk/ravindra-gupta/|access-date=2020-09-23|website=Cambridge Institute of Therapeutic Immunology & Infectious Disease|language=en-GB}}</ref>
* Dissecting the biology of macrophage-virus interactions given myeloid cells are parasitised by HIV and are a difficult-to-treat reservoir.<ref>{{Cite web|title=Ravindra Gupta - CITIID|url=https://www.citiid.cam.ac.uk/ravindra-gupta/|access-date=2020-09-23|website=Cambridge Institute of Therapeutic Immunology & Infectious Disease|language=en-GB}}</ref>
* Dissecting the biology of macrophage-virus interactions given myeloid cells are parasitised by HIV and are a difficult-to-treat reservoir.<ref>{{Cite web|title=Ravindra Gupta - CITIID|url=https://www.citiid.cam.ac.uk/ravindra-gupta/|access-date=2020-09-23|website=Cambridge Institute of Therapeutic Immunology & Infectious Disease|language=en-GB}}</ref>


In March 2019 it was reported that Gupta led a team demonstrating HIV remission in a [[HIV/AIDS|HIV]] positive man with advanced [[Hodgkin's lymphoma]] following an 'unrelated' [[stem cell transplant]], the so-called ''London Patient''.<ref>{{cite web|date=5 March 2019|title=UK man 'free' of HIV with new stem cells|url=https://www.bbc.com/news/health-47421855|accessdate=5 March 2019|website=Bbc.co.uk}}</ref><ref>{{cite web|date=5 March 2019|title=London patient becomes second adult to be cleared of HIV|url=https://www.theguardian.com/society/2019/mar/05/london-patient-becomes-second-man-to-be-cleared-of-aids-virus|accessdate=5 March 2019|website=Theguardian.com|publisher=}}</ref><ref>{{cite web|author=[[Apoorva Mandavilli]]|date=4 March 2019|title=H.I.V. Is Reported Cured in a Second Patient, a Milestone in the Global AIDS Epidemic|url=https://www.nytimes.com/2019/03/04/health/aids-cure-london-patient.html|accessdate=5 March 2019|website=Nytimes.com}}</ref>. After a bone marrow transplant from an HIV-resistant donor, the ''London Patient'' remained "functionally cured"<ref>{{Cite news|last=Kelland|first=Kate|date=2020-07-03|title='Don't give up hope' in fighting viruses, says 'cured' London AIDS patient|language=en|work=Reuters|url=https://www.reuters.com/article/us-health-aids-cure-patient-idUSKBN2441YX|access-date=2020-09-23}}</ref> of his HIV. This is the second case of a patient cured of HIV. The first patient is referred to as ''the [[Berlin Patient]]''.

⚫
He is married with three children.

<br />


==References==
==References==

Revision as of 18:46, 23 September 2020

Professor Ravindra "Ravi" Kumar Gupta is a professor of clinical microbiology at the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge. He is also on faculty of the Africa Health Research Institute in Durban, South Africa.

Gupta was included in Time magazine 's 100 Most Influential People in 2020.[1]

Education

Gupta gained his undergraduate medical degree from Cambridge University in 1997 and then clinical degree from Oxford University in 2001, whilst completing a Master in Public Health at Harvard School of Public Health (1998-1999). He subsequently trained in infectious diseases in Oxford and The Hospital for Tropical Diseases (UCLH).

Biography

Gupta is married with three children.

Career

Gupta's research program centers on HIV, from basic science of how the virus interacts with human cells and the immune system, through to global studies on the emerging problem of drug resistant HIV.

Gupta was formerly Professor at University College London (2016-2019) [2][3] He is head of the Gupta Lab and has been a Wellcome Trust Fellowship holder since 2007.[4]

Gupta's lab has teams in the UK and Durban, South Africa. The lab focuses on two areas:

  • Studying  HIV drug resistance to protease / integrase inhibitors and implications for global scale up of antiretroviral therapy.[5]
  • Dissecting the biology of macrophage-virus interactions given myeloid cells are parasitised by HIV and are a difficult-to-treat reservoir.[6]

In March 2019 it was reported that Gupta led a team demonstrating HIV remission in a HIV positive man with advanced Hodgkin's lymphoma following an 'unrelated' stem cell transplant, the so-called London Patient.[7][8][9]. After a bone marrow transplant from an HIV-resistant donor, the London Patient remained "functionally cured"[10] of his HIV. This is the second case of a patient cured of HIV. The first patient is referred to as the Berlin Patient.

References

  1. ^ "Ravindra Gupta: The 100 Most Influential People of 2020". Time. Retrieved 2020-09-23.
  2. ^ "Professor Ravindra Gupta". Ucl.ac.uk. 28 June 2018. Retrieved 5 March 2019.
  3. ^ "Ravi Gupta". Ahri.org. Retrieved 5 March 2019.
  4. ^ "UCL - London's Global University". Ucl.ac.uk. Retrieved 5 March 2019.
  5. ^ "Ravindra Gupta - CITIID". Cambridge Institute of Therapeutic Immunology & Infectious Disease. Retrieved 2020-09-23.
  6. ^ "Ravindra Gupta - CITIID". Cambridge Institute of Therapeutic Immunology & Infectious Disease. Retrieved 2020-09-23.
  7. ^ "UK man 'free' of HIV with new stem cells". Bbc.co.uk. 5 March 2019. Retrieved 5 March 2019.
  8. ^ "London patient becomes second adult to be cleared of HIV". Theguardian.com. 5 March 2019. Retrieved 5 March 2019.
  9. ^ Apoorva Mandavilli (4 March 2019). "H.I.V. Is Reported Cured in a Second Patient, a Milestone in the Global AIDS Epidemic". Nytimes.com. Retrieved 5 March 2019.
  10. ^ Kelland, Kate (2020-07-03). "'Don't give up hope' in fighting viruses, says 'cured' London AIDS patient". Reuters. Retrieved 2020-09-23.


Stub icon

This biographical article related to medicine is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Ravindra_Gupta&oldid=979952681"